Global Patent Index - EP 0461548 A3

EP 0461548 A3 19920930 - METHOD FOR PREVENTING A SECOND HEART ATTACK EMPLOYING AND HMG COA REDUCTASE INHIBITOR

Title (en)

METHOD FOR PREVENTING A SECOND HEART ATTACK EMPLOYING AND HMG COA REDUCTASE INHIBITOR

Publication

EP 0461548 A3 19920930 (EN)

Application

EP 91109293 A 19910606

Priority

US 53636790 A 19900611

Abstract (en)

[origin: EP0461548A2] A method is provided for preventing or reducing the risk of a second heart attack by administering an HMG CoA reductase inhibitor such as pravastatin, alone or in combination with an ACE inhibitor.

IPC 1-7

A61K 31/365; A61K 31/22; A61K 31/40; A61K 31/66; A61K 31/00

IPC 8 full level

A61K 31/00 (2006.01); A61K 31/22 (2006.01); A61K 31/34 (2006.01); A61K 31/35 (2006.01); A61K 31/365 (2006.01); A61K 31/38 (2006.01); A61K 31/40 (2006.01); A61K 31/401 (2006.01); A61K 31/425 (2006.01); A61K 31/47 (2006.01); A61K 31/55 (2006.01); A61K 31/66 (2006.01); A61K 38/55 (2006.01); A61K 45/00 (2006.01); A61P 3/06 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 43/00 (2006.01)

CPC (source: EP)

A61K 31/00 (2013.01); A61K 31/22 (2013.01); A61K 31/365 (2013.01); A61K 31/40 (2013.01); A61K 31/66 (2013.01); A61K 38/556 (2013.01); A61P 3/06 (2017.12); A61P 9/08 (2017.12); A61P 9/10 (2017.12); A61P 43/00 (2017.12)

C-Set (source: EP)

  1. A61K 38/556 + A61K 31/365
  2. A61K 38/556 + A61K 31/22
  3. A61K 38/556 + A61K 31/40
  4. A61K 38/556 + A61K 31/66
  5. A61K 38/556 + A61K 2300/00

Citation (search report)

  • [AD] DE 3817375 A1 19881208 - SQUIBB & SONS INC [US]
  • [AD] DE 3817298 A1 19881201 - SQUIBB & SONS INC [US]
  • [E] EP 0459453 A2 19911204 - SQUIBB & SONS INC [US]
  • [A] EP 0373507 A1 19900620 - SQUIBB & SONS INC [US]
  • [XP] EP 0425956 A2 19910508 - SQUIBB & SONS INC [US]
  • [X] PATENT ABSTRACTS OF JAPAN, vol. 7, no. 209 (C-186)[1354], 14th September 1983; & JP-A-58 109 416 (SANKYO K.K.) 29-06-1983
  • [X] PATENT ABSTRACTS OF JAPAN, vol. 6, no. 49 (C-96)[927], 31st March 1982; & JP-A-56 164 116 (SANKYO K.K.) 17-12-1981
  • [X] JAPAN J. PHARMACOL., vol. 49, January 1989, pages 125-133; M. KOBAYASHI et al.: "Preventive effect of MK-733 (simvastatin), an inhibitor of HMG-CoA reductase, on hypercholesterolemia and atherosclerosis induced by cholesterol feeding in rabbits"
  • [X] THERAPEUTISCHE UMSCHAU, vol. 47, no. 6, June 1990, pages 520-529; J. THIERY et al.: "Maximaltherapie der Hypercholesterinämie bei koronarer Herzerkrankung"
  • [X] CARDIOLOGICA, vol. 34, no. 12, 1989, pages 1027-1034; A. STRANO et al.: "Effetti di un trattamento cronico con simvastatina, un inibitore dell HMG-CoA reduttasi, in pazienti dislipidemici ad alto rischio"
  • [X] EUROPEAN HEART JOURNAL, vol. 9, 1988, pages 541-551, The European Society of Cardiology; J. MÖLGAARD et al.: "Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia"

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB GR IT LI LU NL SE

DOCDB simple family (publication)

EP 0461548 A2 19911218; EP 0461548 A3 19920930; AU 7719291 A 19911212; CA 2042526 A1 19911212; HU 911931 D0 19911230; IE 911910 A1 19911218; JP H04243839 A 19920831; ZA 913922 B 19920226

DOCDB simple family (application)

EP 91109293 A 19910606; AU 7719291 A 19910520; CA 2042526 A 19910514; HU 193191 A 19910610; IE 191091 A 19910605; JP 13889391 A 19910611; ZA 913922 A 19910523